Nu Skin Enterprises Inc. (NYSE:NUS) has been assigned an average recommendation of “Hold” from the eleven ratings firms that are covering the company. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $51.91.
Several research firms have weighed in on NUS. Jefferies Group set a $46.00 target price on Nu Skin Enterprises and gave the company a “hold” rating in a report on Monday, July 25th. Pivotal Research lifted their price objective on Nu Skin Enterprises from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Deutsche Bank AG lifted their price objective on Nu Skin Enterprises from $55.00 to $57.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective on the stock in a research note on Tuesday, June 21st. Finally, Stifel Nicolaus lifted their price objective on Nu Skin Enterprises from $34.00 to $45.00 and gave the stock a “sell” rating in a research note on Friday, August 5th.
In related news, Director Andrew D. Lipman sold 30,000 shares of Nu Skin Enterprises stock in a transaction dated Thursday, September 22nd. The stock was sold at an average price of $64.13, for a total transaction of $1,923,900.00. Following the sale, the director now directly owns 36,090 shares of the company’s stock, valued at $2,314,451.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 4.60% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. GSA Capital Partners LLP increased its stake in Nu Skin Enterprises by 234.4% in the second quarter. GSA Capital Partners LLP now owns 72,436 shares of the company’s stock worth $3,346,000 after buying an additional 50,774 shares during the period. Zebra Capital Management LLC purchased a new stake in Nu Skin Enterprises during the first quarter worth $519,000. OMERS ADMINISTRATION Corp purchased a new stake in Nu Skin Enterprises during the first quarter worth $2,073,000. Spark Investment Management LLC purchased a new stake in Nu Skin Enterprises during the first quarter worth $2,092,000. Finally, Menta Capital LLC increased its stake in Nu Skin Enterprises by 139.7% in the first quarter. Menta Capital LLC now owns 18,100 shares of the company’s stock worth $692,000 after buying an additional 10,550 shares during the period. 77.08% of the stock is currently owned by institutional investors and hedge funds.
Shares of Nu Skin Enterprises (NYSE:NUS) opened at 64.66 on Thursday. Nu Skin Enterprises has a 12 month low of $23.51 and a 12 month high of $66.04. The firm has a market capitalization of $3.62 billion, a PE ratio of 37.10 and a beta of 1.84. The stock’s 50 day moving average price is $60.75 and its 200-day moving average price is $48.34.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, August 4th. The company reported $0.79 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.01. Nu Skin Enterprises had a return on equity of 18.46% and a net margin of 4.52%. The company had revenue of $600.05 million for the quarter, compared to analyst estimates of $578.87 million. During the same period last year, the company earned $0.75 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. On average, equities analysts anticipate that Nu Skin Enterprises will post $2.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 14th. Investors of record on Friday, August 26th were given a dividend of $0.355 per share. This represents a $1.42 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 81.14%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.